ArticleClinical interventions in aging2026
Screening for Geriatric Problems in Older Adults Receiving Hemodialysis Using a Self-Administered Battery.
Article in Clinical interventions in aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Purpose: Older adults receiving hemodialysis experience geriatric problems that affect quality of life and contribute to high healthcare utilization but are often underrecognized in dialysis care. Scalable approaches to identifying these problems are needed. This study evaluated the agreement between a self-administered screening battery and a geriatrician telehealth evaluation and assessed the feasibility of implementing the screening battery in dialysis clinics. Patients and Methods: Participants aged ≥55 receiving hemodialysis completed the Geriatric screen for Older adults receiving Dialysis (GOLD), a screening battery assessing seven geriatric problems: depression, anxiety, functional impairment, cognitive impairment, falls risk, limited social support, and low nutritional status, followed by a blinded geriatrician telehealth evaluation. Intra-problem agreement between the GOLD and geriatrician evaluation was assessed using Cohen's κ, and analyses evaluated alternative screening thresholds. Acceptability and feasibility of the GOLD were evaluated through participant and staff surveys. Results: The cohort included 50 participants [76% (n=38) Black race, 62% (n=31) male, 16% (n=8) Hispanic/Latino ethnicity] with a mean (SD) age of 68 (7.8) years and a median dialysis vintage of 3.5 [IQR (1, 12.5)] years. Geriatric problems were common, including fall risk (78% geriatrician; 90% GOLD), functional impairment (58% geriatrician; 44% GOLD), and low nutritional status (50% geriatrician; 40% GOLD). Agreement between the GOLD and geriatrician evaluation was substantial for anxiety (κ=0.74), functional impairment (κ=0.65), low nutritional status (κ=0.64), and limited social support (κ=0.65), but not for cognitive impairment, falls risk, or depression. Most participants (37 of 45) reported the GOLD was easy to complete, and a minority (16 of 50) required assistance. Conclusion: The GOLD demonstrated agreement with geriatrician evaluation for many geriatric problems and was feasible to implement in dialysis clinics. These findings suggest potential utility for scalable geriatric screening in dialysis care, although further work is needed to confirm these findings in larger cohorts and to refine screening for cognitive impairment and other domains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.